UROKINASE-TYPE PLASMINOGEN ACTIVATOR AND INHIBITOR AS PROGNOSTIC MARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER AND LYMPH NODE METASTASES

被引：0
作者：
Lumachi, F. [1 ]
Marino, F. [2 ]
Santeufemia, D. A. [3 ]
Chiara, G. B. [3 ]
Basso, S. M. [3 ]
机构：
[1] Univ Padua, Sch Med, Dept Surg & Gastroenterol Sci, Padua, Italy
[2] Univ Padua, Dept Pathol, Sch Med, I-35100 Padua, Italy
[3] S Maria Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
[21]   Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 [J].
Jänicke, F ;
Prechtl, A ;
Thomssen, C ;
Harbeck, N ;
Meisner, C ;
Untch, M ;
Sweep, CGJF ;
Selbmann, HK ;
Graeff, H ;
Schmitt, M .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (12) :913-920
[22]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 I IN BREAST-CANCER CELLS [J].
WAJIMA, T ;
DEGEN, D ;
ORIZ, V ;
VONHOFFOLIN, DD .
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) :1284-1284
[23]   Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 as a prognostic factor in human colorectal carcinomas [J].
Fujii, T ;
Obara, T ;
Tanno, S ;
Ura, H ;
Kohgo, Y .
HEPATO-GASTROENTEROLOGY, 1999, 46 (28) :2299-2308
[24]   Immunostaining for detecting lymph node metastases in non-small cell lung cancer [J].
Sioris, T ;
Helin, H ;
Järvenpää, R ;
Lahdensuo, A ;
Tarkka, M .
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2000, 34 (05) :536-540
[25]   Surgical Treatment Outcomes of Patients with Non-Small Cell Lung Cancer and Lymph Node Metastases [J].
Shimizu, Yuki ;
Koike, Terumoto ;
Hasebe, Toshiki ;
Nakamura, Masaya ;
Goto, Tatsuya ;
Toyabe, Shin-ichi ;
Tsuchida, Masanori .
CANCERS, 2023, 15 (12)
[26]   Plasminogen activator inhibitor 2 and urokinase-type plasminogen activator in plasma and leucocytes in patients with severe sepsis [J].
Robbie, LA ;
Dummer, S ;
Booth, NA ;
Adey, GD ;
Bennett, B .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 109 (02) :342-348
[27]   Urokinase-type plasminogen activator and its inhibitor PAI-1 as prognostic factors in cervical cancer [J].
Köhler, U ;
Martin, R ;
Pippig, S ;
Horn, LC .
GEBURTSHILFE UND FRAUENHEILKUNDE, 1999, 59 (10) :513-518
[28]   Prognostic roles of lymph node micrometastasis in non-small cell lung cancer [J].
Jeong, Jae Han ;
Kim, Nae Yu ;
Pyo, Jung-Soo .
PATHOLOGY RESEARCH AND PRACTICE, 2018, 214 (02) :240-244
[29]   The prognostic value of urokinase-type plasminogen activator, its receptor, and plasminogen activator inhibitor-2 in esophageal squamous cell carcinoma [J].
Shiomi, H ;
Eguchi, Y ;
Tani, T ;
Hattori, T ;
Kodama, M .
THROMBOSIS AND HAEMOSTASIS, 1999, :601-601
[30]   Postoperative Prognostic Factors in Non-Small Cell Lung Cancer Patients with Lymph Node Metastasis [J].
Goto, T. ;
Nakamura, A. ;
Kitahara, A. ;
Sato, S. ;
Koike, T. ;
Tsuchida, M. .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2343-S2344
12345